Medicare Enrolled

Dr. Timothy Daniel, MD

Endocrinology · Pearland, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
10970 SHADOW CREEK PKWY, Pearland, TX 77584
8666934223
In practice since 2006 (19 years)
NPI: 1770679573 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Daniel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Daniel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Daniel

Dr. Timothy Daniel is an endocrinology in Pearland, TX, with 19 years in practice. Based on federal Medicare data, Dr. Daniel performed 1,781 Medicare services across 999 unique beneficiaries.

Between the years covered by Open Payments, Dr. Daniel received a total of $84,126 from 47 pharmaceutical and/or device companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Daniel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 24% volume in TX$ $84,126 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,781
Medicare services
Top 24% in TX for endocrinology
999
Unique beneficiaries
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~94 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (30-39 min)526$92$292
Hemoglobin A1c test (diabetes monitoring)423$9$25
Blood glucose (sugar) test performed by hand-held instrument386$3$7
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report142$27$77
Blood glucose (sugar) level100$4$8
Diabetes outpatient self-management training services, individual, per 30 minutes59$41$124
Lipid panel (cholesterol and triglycerides)19$13$40
Free thyroxine (T4) test19$9$20
New patient office visit (45-59 min)19$114$376
Urine microalbumin test (kidney screening)18$5$12
Thyroid stimulating hormone (TSH) test18$16$50
Complete blood count (CBC) with differential18$8$20
Comprehensive metabolic blood panel17$10$31
Creatinine test (kidney function)17$5$11
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$84,126
Total received (2018-2024)
Avg $12,018/year across 7 years
Top 12% in TX for endocrinology
47
Companies
552
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$76,870 (91.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,256 (8.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$7,104
2023
$16,849
2022
$8,151
2021
$7,396
2020
$6,302
2019
$18,674
2018
$19,650

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$56,059
SANOFI-AVENTIS U.S. LLC
$13,813
Novo Nordisk Inc
$7,814
Bayer HealthCare Pharmaceuticals Inc.
$904
Amarin Pharma Inc.
$846
Lilly USA, LLC
$666
AstraZeneca Pharmaceuticals LP
$373
Janssen Pharmaceuticals, Inc
$370
ABBVIE INC.
$309
Corcept Therapeutics
$232
Amgen Inc.
$201
Bayer Healthcare Pharmaceuticals Inc.
$186
Insulet Corporation
$163
PFIZER INC.
$154
AbbVie Inc.
$151
Medtronic MiniMed, Inc.
$143
Medtronic, Inc.
$139
Tandem Diabetes Care, Inc.
$138
Dexcom, Inc.
$137
Biohaven Pharmaceutical Holding Company Ltd.
$128
Embecta Corp.
$114
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$112
Merck Sharp & Dohme LLC
$96
Exact Sciences Corporation
$83
Merck Sharp & Dohme Corporation
$80
Mylan Specialty L.P.
$75
GlaxoSmithKline, LLC.
$73
Xeris Pharmaceuticals, Inc.
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$54
Becton, Dickinson and Company
$44
IDORSIA PHARMACEUTICALS US INC
$43
LifeScan, Inc.
$38
Inari Medical, Inc.
$34
Astellas Pharma US Inc
$28
Companion Medical, Inc.
$27
Phathom Pharmaceuticals, Inc.
$27
Takeda Pharmaceuticals U.S.A., Inc.
$26
Edwards Lifesciences Corporation
$24
Mannkind Corporation
$22
Currax Pharmaceuticals LLC
$22
Smith & Nephew, Inc.
$20
Musculoskeletal Transplant Foundation Inc.
$20
Intuity Medical Inc
$19
Eisai Inc.
$19
Tactile Systems Technology Inc
$17
Allergan Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Top 3 companies account for 92.3% of total payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AMPLATZER · Aimovig · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BELSOMRA · BYSTOLIC · CHANTIX · CONTRAVE · COREVALVE EVOLUT R · CREON · CYCLOSET · Cologuard Collection Kit · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DIABETES - DISEASE · Dayvigo · Dexcom CGM · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Freedom Lite system · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Lite system · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · INVOKANA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · Livalo · MINIMED 770G · MOUNJARO · Minimed 670G System · NURTEC ODT · Omnipod · OneTouch · Otezla · Ozempic · PREVNAR 20 · Pogo Automatic Blood Glucose Monitoring System · QULIPTA · QUVIVIQ · Rybelsus · S · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · Santyl · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · TZIELD · Tresiba · UBRELVY · VERQUVO · VIBERZI · VOQUEZNA · VRAYLAR · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Yupelri · t-slim insulin pump · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Equivalent to $4,724 per 100 Medicare services performed
Looking for a endocrinology in Pearland?
Compare endocrinologys in the Pearland area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
122
Per 100K population
32.0
County median income
$95,155
Nearest hospital
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Daniel is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), and high industry engagement (consulting-driven, top 12%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Daniel experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Daniel performed 526 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Daniel receive payments from pharmaceutical companies?
Yes. Dr. Daniel received a total of $84,126 from 47 companies across 552 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Daniel's costs compare to other endocrinologys in Pearland?
Dr. Daniel's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Daniel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →